{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T09:22:45Z","timestamp":1763457765359,"version":"build-2065373602"},"reference-count":81,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Obstetrics and Gynecology Clinics of North America"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.ogc.2018.09.007","type":"journal-article","created":{"date-parts":[[2019,1,25]],"date-time":"2019-01-25T08:12:29Z","timestamp":1548403949000},"page":"107-123","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["(At Least) Once in Her Lifetime: Global Cervical Cancer Prevention"],"prefix":"10.1016","volume":"46","author":[{"given":"Philip E.","family":"Castle","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanda","family":"Pierz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"year":"2013","series-title":"GLOBOCAN 2012 v1.0, cancer incidence and mortality worldwide: IARC CancerBase No. 11","author":"Ferlay","key":"10.1016\/j.ogc.2018.09.007_bib1"},{"key":"10.1016\/j.ogc.2018.09.007_bib2","unstructured":"Cervix cancer screening. IARC Press, IARC Handbooks of Cancer Prevention, Volume 10. 2005."},{"issue":"Suppl 3","key":"10.1016\/j.ogc.2018.09.007_bib3","first-page":"S3\/63-70","article-title":"Chapter 7: achievements and limitations of cervical cytology screening","volume":"24","author":"Kitchener","year":"2006","journal-title":"Vaccine"},{"year":"2010","series-title":"GLOBOCAN 2008 v2.0, cancer incidence and mortality worldwide: IARC CancerBase No. 10","author":"Ferlay","key":"10.1016\/j.ogc.2018.09.007_bib4"},{"key":"10.1016\/j.ogc.2018.09.007_bib5","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0140-6736(07)61050-2","article-title":"Incidence of cancers in people with HIV\/AIDS compared with immunosuppressed transplant recipients: a meta-analysis","volume":"370","author":"Grulich","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.ogc.2018.09.007_bib6","doi-asserted-by":"crossref","first-page":"3812","DOI":"10.1073\/pnas.80.12.3812","article-title":"A\u00a0papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions","volume":"80","author":"Durst","year":"1983","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"key":"10.1016\/j.ogc.2018.09.007_bib7","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/S0140-6736(07)61416-0","article-title":"Human papillomavirus and cervical cancer","volume":"370","author":"Schiffman","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.ogc.2018.09.007_bib8","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.ygyno.2017.12.001","article-title":"A\u00a0systematic review and meta-analysis on the attribution of human papillomavirus (HPV) in neuroendocrine cancers of the cervix","volume":"148","author":"Castle","year":"2018","journal-title":"Gynecol Oncol"},{"issue":"Suppl 5","key":"10.1016\/j.ogc.2018.09.007_bib9","doi-asserted-by":"crossref","first-page":"F12","DOI":"10.1016\/j.vaccine.2012.07.055","article-title":"Global burden of human papillomavirus and related diseases","volume":"30","author":"Forman","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.ogc.2018.09.007_bib10","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/S1470-2045(10)70230-8","article-title":"Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study","volume":"11","author":"de","year":"2010","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ogc.2018.09.007_bib11","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1093\/cid\/cix475","article-title":"Age of acquiring causal human papillomavirus (HPV) infections: leveraging simulation models to explore the natural history of HPV-induced cervical cancer","volume":"65","author":"Burger","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ogc.2018.09.007_bib12","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1093\/jnci\/djp534","article-title":"Impact of human papillomavirus (HPV)-6\/11\/16\/18 vaccine on all HPV-associated genital diseases in young women","volume":"102","author":"Munoz","year":"2010","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.ogc.2018.09.007_bib13","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S1470-2045(11)70286-8","article-title":"Overall efficacy of HPV-16\/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial","volume":"13","author":"Lehtinen","year":"2012","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ogc.2018.09.007_bib14","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/S1473-3099(12)70187-1","article-title":"Cross-protective efficacy of two human papillomavirus vaccines: a systematic review and meta-analysis","volume":"12","author":"Malagon","year":"2012","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ogc.2018.09.007_bib15","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1056\/NEJMoa1405044","article-title":"A\u00a09-valent HPV vaccine against infection and intraepithelial neoplasia in women","volume":"372","author":"Joura","year":"2015","journal-title":"N\u00a0Engl J Med"},{"year":"2014","series-title":"Human papillomavirus vaccines: WHO position paper, October 2014","key":"10.1016\/j.ogc.2018.09.007_bib16"},{"key":"10.1016\/j.ogc.2018.09.007_bib17","first-page":"630","article-title":"FDA licensure of quadrivalent human papillomavirus vaccine (HPV4, Gardasil) for use in males and guidance from the Advisory Committee on Immunization Practices (ACIP)","volume":"59","author":"Centers for Disease Control and Prevention (CDC)","year":"2010","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.ogc.2018.09.007_bib18","unstructured":"World Health Organization. Immunization, vaccines and biologicals: human papillomavirus (HPV). 2018. Available at: http:\/\/www.who.int\/immunization\/diseases\/hpv\/en\/. Accessed March 27, 2018."},{"key":"10.1016\/j.ogc.2018.09.007_bib19","unstructured":"Centers for Disease Control and Prevention. CDC recommends only two HPV shots for younger adolescents. 2016. Available at: https:\/\/www.cdc.gov\/media\/releases\/2016\/p1020-hpv-shots.html. Accessed March 27, 2018."},{"key":"10.1016\/j.ogc.2018.09.007_bib20","doi-asserted-by":"crossref","first-page":"S40","DOI":"10.1016\/j.jadohealth.2016.07.005","article-title":"Systematic review and meta-analysis of interventions to improve access and coverage of adolescent immunizations","volume":"59","author":"Das","year":"2016","journal-title":"J\u00a0Adolesc Health"},{"key":"10.1016\/j.ogc.2018.09.007_bib21","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1186\/1741-7015-11-227","article-title":"Impact of a population-based HPV vaccination program on cervical abnormalities: a data linkage study","volume":"11","author":"Gertig","year":"2013","journal-title":"BMC Med"},{"key":"10.1016\/j.ogc.2018.09.007_bib22","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/S1473-3099(17)30468-1","article-title":"Changes in the prevalence of human papillomavirus following a national bivalent human papillomavirus vaccination programme in Scotland: a 7-year cross-sectional study","volume":"17","author":"Kavanagh","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ogc.2018.09.007_bib23","doi-asserted-by":"crossref","first-page":"djt460","DOI":"10.1093\/jnci\/djt460","article-title":"Early impact of human papillomavirus vaccination on cervical neoplasia\u2014nationwide follow-up of young Danish women","volume":"106","author":"Baldur-Felskov","year":"2014","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.ogc.2018.09.007_bib24","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1093\/infdis\/jix244","article-title":"Prevalence of human papillomavirus among females after vaccine introduction-national health and nutrition examination survey, United States, 2003-2014","volume":"216","author":"Oliver","year":"2017","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.ogc.2018.09.007_bib25","unstructured":"National HPV Vaccination Program Register. Coverage Data. 2018. Available at: http:\/\/www.hpvregister.org.au\/research\/coverage-data. Accessed March 27, 2018."},{"key":"10.1016\/j.ogc.2018.09.007_bib26","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S1473-3099(10)70225-5","article-title":"Quadrivalent human papillomavirus vaccination and trends in genital warts in Australia: analysis of national sentinel surveillance data","volume":"11","author":"Donovan","year":"2011","journal-title":"Lancet Infect Dis"},{"issue":"10","key":"10.1016\/j.ogc.2018.09.007_bib27","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1093\/infdis\/jiy075","article-title":"Very low prevalence of vaccine human papillomavirus (HPV) types among 18 to 35 year old Australian women, nine years following implementation of vaccination","volume":"217","author":"Machalek","year":"2018","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.ogc.2018.09.007_bib28","doi-asserted-by":"crossref","first-page":"184","DOI":"10.5694\/mja15.01038","article-title":"HPV vaccine impact in Australian women: ready for an HPV-based screening program","volume":"204","author":"Brotherton","year":"2016","journal-title":"Med J Aust"},{"key":"10.1016\/j.ogc.2018.09.007_bib29","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1002\/ijc.31231","article-title":"Vaccination protects against invasive HPV-associated cancers","volume":"142","author":"Luostarinen","year":"2018","journal-title":"Int J Cancer"},{"year":"2017","series-title":"Safety update of HPV vaccines","author":"Global Advisory Committee on Vaccine Safety (GACVS)","key":"10.1016\/j.ogc.2018.09.007_bib30"},{"year":"2016","series-title":"Human papillomavirus vaccines","author":"European Medicines Agency","key":"10.1016\/j.ogc.2018.09.007_bib31"},{"year":"2018","series-title":"Human papillomavirus (HPV) vaccine safety","author":"Centers for Disease Control and Prevention","key":"10.1016\/j.ogc.2018.09.007_bib32"},{"key":"10.1016\/j.ogc.2018.09.007_bib33","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s40264-017-0625-z","article-title":"Safety of human papillomavirus vaccines: an updated review","volume":"41","author":"Phillips","year":"2018","journal-title":"Drug Saf"},{"key":"10.1016\/j.ogc.2018.09.007_bib34","first-page":"3736201","article-title":"Safety of human papillomavirus 9-valent vaccine: a meta-analysis of randomized trials","volume":"2017","author":"Costa","year":"2017","journal-title":"J\u00a0Immunol Res"},{"key":"10.1016\/j.ogc.2018.09.007_bib35","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s40780-017-0087-6","article-title":"Safety of human papillomavirus vaccines in healthy young women: a meta-analysis of 24 controlled studies","volume":"3","author":"Ogawa","year":"2017","journal-title":"J\u00a0Pharm Health Care Sci"},{"key":"10.1016\/j.ogc.2018.09.007_bib36","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.vaccine.2017.12.042","article-title":"Antibody responses among adolescent females receiving two or three quadrivalent human papillomavirus vaccine doses at standard and prolonged intervals","volume":"36","author":"Widdice","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.ogc.2018.09.007_bib37","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1001\/jama.2011.407","article-title":"Immunogenicity and reactogenicity of alternative schedules of HPV vaccine in Vietnam: a cluster randomized noninferiority trial","volume":"305","author":"Neuzil","year":"2011","journal-title":"JAMA"},{"issue":"7","key":"10.1016\/j.ogc.2018.09.007_bib38","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/S1470-2045(15)00047-9","article-title":"Efficacy of fewer than three doses of an HPV-16\/18 AS04-adjuvanted vaccine: combined analysis of data from the Costa Rica Vaccine and PATRICIA trials","volume":"16","author":"Kreimer","year":"2015","journal-title":"Lancet Oncol"},{"issue":"32 Pt A","key":"10.1016\/j.ogc.2018.09.007_bib39","doi-asserted-by":"crossref","first-page":"4783","DOI":"10.1016\/j.vaccine.2018.02.087","article-title":"Can a single dose of human papillomavirus (HPV) vaccine prevent cervical cancer? Early findings from an Indian study","volume":"36","author":"Sankaranarayanan","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.ogc.2018.09.007_bib40","doi-asserted-by":"crossref","first-page":"g1458","DOI":"10.1136\/bmj.g1458","article-title":"Effectiveness of quadrivalent human papillomavirus vaccine for the prevention of cervical abnormalities: case-control study nested within a population based screening programme in Australia","volume":"348","author":"Crowe","year":"2014","journal-title":"BMJ"},{"key":"10.1016\/j.ogc.2018.09.007_bib41","doi-asserted-by":"crossref","first-page":"e453","DOI":"10.1016\/S2214-109X(16)30099-7","article-title":"Global estimates of human papillomavirus vaccination coverage by region and income level: a pooled analysis","volume":"4","author":"Bruni","year":"2016","journal-title":"Lancet Glob Health"},{"issue":"Suppl 1","key":"10.1016\/j.ogc.2018.09.007_bib42","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/ijgo.12186","article-title":"Progress in HPV vaccination in low- and lower-middle-income countries","volume":"138","author":"LaMontagne","year":"2017","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.ogc.2018.09.007_bib43","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1056\/NEJMoa061760","article-title":"Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases","volume":"356","author":"Garland","year":"2007","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ogc.2018.09.007_bib44","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1001\/jama.298.7.743","article-title":"Effect of human papillomavirus 16\/18 L1 viruslike particle vaccine among young women with preexisting infection: a randomized trial","volume":"298","author":"Hildesheim","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.ogc.2018.09.007_bib45","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1093\/jnci\/djq382","article-title":"Preventing cervical cancer globally by acting locally: if not now, when?","volume":"102","author":"Gage","year":"2010","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.ogc.2018.09.007_bib46","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1002\/ijc.21955","article-title":"Overview of the European and North American studies on HPV testing in primary cervical cancer screening","volume":"119","author":"Cuzick","year":"2006","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ogc.2018.09.007_bib47","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S1470-2045(11)70296-0","article-title":"Human papillomavirus testing for the detection of high-grade cervical intraepithelial neoplasia and cancer: final results of the POBASCAM randomised controlled trial","volume":"13","author":"Rijkaart","year":"2012","journal-title":"Lancet Oncol"},{"issue":"3","key":"10.1016\/j.ogc.2018.09.007_bib48","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S1470-2045(09)70360-2","article-title":"Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial","volume":"11","author":"Ronco","year":"2010","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ogc.2018.09.007_bib49","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/S1470-2045(11)70188-7","article-title":"Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study","volume":"12","author":"Castle","year":"2011","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ogc.2018.09.007_bib50","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1309\/BA43HMCAJ26VWQH3","article-title":"Interlaboratory reliability of hybrid capture 2","volume":"122","author":"Castle","year":"2004","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.ogc.2018.09.007_bib51","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1309\/84E5WHJQHK83BGQD","article-title":"Reproducibility of HPV DNA testing by hybrid capture 2 in a screening setting","volume":"124","author":"Carozzi","year":"2005","journal-title":"Am J Clin Pathol"},{"issue":"9916","key":"10.1016\/j.ogc.2018.09.007_bib52","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/S0140-6736(13)62218-7","article-title":"Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials","volume":"383","author":"Ronco","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.ogc.2018.09.007_bib53","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1056\/NEJMoa0808516","article-title":"HPV screening for cervical cancer in rural India","volume":"360","author":"Sankaranarayanan","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ogc.2018.09.007_bib54","doi-asserted-by":"crossref","first-page":"a1754","DOI":"10.1136\/bmj.a1754","article-title":"Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: joint European cohort study","volume":"337","author":"Dillner","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.ogc.2018.09.007_bib55","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1056\/NEJMp058171","article-title":"The promise of global cervical-cancer prevention","volume":"353","author":"Schiffman","year":"2005","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ogc.2018.09.007_bib56","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/S1470-2045(13)70570-9","article-title":"Accuracy of human papillomavirus testing on self-collected versus clinician-collected samples: a meta-analysis","volume":"15","author":"Arbyn","year":"2014","journal-title":"Lancet Oncol"},{"issue":"9","key":"10.1016\/j.ogc.2018.09.007_bib57","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1002\/ijc.29594","article-title":"Cervical cancer screening in low-resource settings: a cost-effectiveness framework for valuing tradeoffs between test performance and program coverage","volume":"137","author":"Campos","year":"2015","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ogc.2018.09.007_bib58","doi-asserted-by":"crossref","first-page":"e85","DOI":"10.1016\/S2214-109X(14)70354-7","article-title":"Effect of self-collection of HPV DNA offered by community health workers at home visits on uptake of screening for cervical cancer (the EMA study): a population-based cluster-randomised trial","volume":"3","author":"Arrossi","year":"2015","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.ogc.2018.09.007_bib59","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.ypmed.2011.03.018","article-title":"Comparative community outreach to increase cervical cancer screening in the Mississippi Delta","volume":"52","author":"Castle","year":"2011","journal-title":"Prev Med"},{"key":"10.1016\/j.ogc.2018.09.007_bib60","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1016\/j.ejca.2015.07.006","article-title":"Reaching women who do not participate in the regular cervical cancer screening programme by offering self-sampling kits: a systematic review and meta-analysis of randomised trials","volume":"51","author":"Verdoodt","year":"2015","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ogc.2018.09.007_bib61","doi-asserted-by":"crossref","first-page":"501","DOI":"10.2147\/PPA.S69286","article-title":"Exploring barriers to the delivery of cervical cancer screening and early treatment services in Malawi: some views from service providers","volume":"9","author":"Munthali","year":"2015","journal-title":"Patient Prefer Adherence"},{"key":"10.1016\/j.ogc.2018.09.007_bib62","first-page":"756","article-title":"Barriers to cervical cancer screening in rural Kenya: perspectives from a provider survey","volume":"40","author":"Rosser","year":"2015","journal-title":"J\u00a0Community Health"},{"key":"10.1016\/j.ogc.2018.09.007_bib63","doi-asserted-by":"crossref","first-page":"e152","DOI":"10.1016\/S1470-2045(12)70598-3","article-title":"Improvement of pathology in sub-Saharan Africa","volume":"14","author":"Adesina","year":"2013","journal-title":"Lancet Oncol"},{"year":"2013","series-title":"New guidelines on screening and treatment for cervical cancer","author":"World Health Organization","key":"10.1016\/j.ogc.2018.09.007_bib64"},{"key":"10.1016\/j.ogc.2018.09.007_bib65","doi-asserted-by":"crossref","first-page":"10516","DOI":"10.1073\/pnas.1202684109","article-title":"A\u00a0discrete population of squamocolumnar junction cells implicated in the pathogenesis of cervical cancer","volume":"109","author":"Herfs","year":"2012","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"key":"10.1016\/j.ogc.2018.09.007_bib66","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1002\/cam4.1089","article-title":"Cervical cancer screening in a low-resource setting: a pilot study on an HPV-based screen-and-treat approach","volume":"6","author":"Kunckler","year":"2017","journal-title":"Cancer Med"},{"key":"10.1016\/j.ogc.2018.09.007_bib67","doi-asserted-by":"crossref","first-page":"2891","DOI":"10.1002\/ijc.28616","article-title":"Lower cost strategies for triage of human papillomavirus DNA-positive women","volume":"134","author":"Qiao","year":"2014","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ogc.2018.09.007_bib68","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1363\/3514709","article-title":"Evidence-based, alternative cervical cancer screening approaches in low-resource settings","volume":"35","author":"Sherris","year":"2009","journal-title":"Int Perspect Sex Reprod Health"},{"key":"10.1016\/j.ogc.2018.09.007_bib69","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1093\/jnci\/djq562","article-title":"Human papillomavirus testing in the prevention of cervical cancer","volume":"103","author":"Schiffman","year":"2011","journal-title":"J\u00a0Natl Cancer Inst"},{"year":"2014","series-title":"FDA approves first human papillomavirus test for primary cervical cancer screening","key":"10.1016\/j.ogc.2018.09.007_bib70"},{"year":"2018","series-title":"BD Onclarity HPV assay - P160037","key":"10.1016\/j.ogc.2018.09.007_bib71"},{"key":"10.1016\/j.ogc.2018.09.007_bib72","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.cmi.2015.04.015","article-title":"Which high-risk HPV assays fulfil criteria for use in primary cervical cancer screening?","volume":"21","author":"Arbyn","year":"2015","journal-title":"Clin Microbiol Infect"},{"issue":"Suppl 3","key":"10.1016\/j.ogc.2018.09.007_bib73","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.1097\/QAI.0b013e31825ca721","article-title":"The United States president's emergency plan for AIDS relief: a story of partnerships and smart investments to turn the tide of the global AIDS pandemic","volume":"60","author":"Goosby","year":"2012","journal-title":"J\u00a0Acquir Immune Defic Syndr"},{"key":"10.1016\/j.ogc.2018.09.007_bib74","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/LGT.0000000000000280","article-title":"Scale-up of an human papillomavirus testing implementation program in El salvador","volume":"21","author":"Cremer","year":"2017","journal-title":"J\u00a0Low Genit Tract Dis"},{"key":"10.1016\/j.ogc.2018.09.007_bib75","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1097\/IGC.0000000000000084","article-title":"A\u00a0multicountry evaluation of careHPV testing, visual inspection with acetic acid, and papanicolaou testing for the detection of cervical cancer","volume":"24","author":"Jeronimo","year":"2014","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ogc.2018.09.007_bib76","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S1470-2045(08)70210-9","article-title":"A\u00a0new HPV-DNA test for cervical-cancer screening in developing regions: a cross-sectional study of clinical accuracy in rural China","volume":"9","author":"Qiao","year":"2008","journal-title":"Lancet Oncol"},{"year":"2011","series-title":"UN political declaration on NCDs","author":"United Nations","key":"10.1016\/j.ogc.2018.09.007_bib77"},{"key":"10.1016\/j.ogc.2018.09.007_bib78","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1056\/NEJMp1602825","article-title":"Time for a model list of essential diagnostics","volume":"374","author":"Schroeder","year":"2016","journal-title":"N\u00a0Engl J Med"},{"year":"2018","series-title":"World Health Organization model list of essential in vitro diagnostics","author":"World Health Organization","key":"10.1016\/j.ogc.2018.09.007_bib79"},{"key":"10.1016\/j.ogc.2018.09.007_bib80","doi-asserted-by":"crossref","first-page":"djw216","DOI":"10.1093\/jnci\/djw216","article-title":"Optimal cervical cancer screening in women vaccinated against human papillomavirus","volume":"109","author":"Kim","year":"2016","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.ogc.2018.09.007_bib81","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/nrclinonc.2015.146","article-title":"HPV-FASTER: broadening the scope for prevention of HPV-related cancer","volume":"13","author":"Bosch","year":"2016","journal-title":"Nat Rev Clin Oncol"}],"container-title":["Obstetrics and Gynecology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889854518300950?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889854518300950?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T10:18:09Z","timestamp":1760177889000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889854518300950"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":81,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["S0889854518300950"],"URL":"https:\/\/doi.org\/10.1016\/j.ogc.2018.09.007","relation":{},"ISSN":["0889-8545"],"issn-type":[{"type":"print","value":"0889-8545"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"(At Least) Once in Her Lifetime: Global Cervical Cancer Prevention","name":"articletitle","label":"Article Title"},{"value":"Obstetrics and Gynecology Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ogc.2018.09.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}